Android app on Google Play

Orexigen Therapeutics, Inc. (OREX) Posts Q4 Loss of 9c/Share

March 8, 2012 4:01 PM EST Send to a Friend
Get Alerts OREX Hot Sheet
Trade OREX Now!
Join SI Premium – FREE
Orexigen Therapeutics, Inc. (NASDAQ: OREX) reported Q4 EPS of ($0.09), $0.01 better than the analyst estimate of ($0.10). Revenue for the quarter came in at $857 thousand versus the consensus estimate of $940 thousand.

For earnings history and earnings-related data on Orexigen Therapeutics, Inc. (OREX) click here.

You May Also Be Interested In

Related Categories


Related Entities


Add Your Comment